Preferred Label : Interleukin-6;
MeSH definition : A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is
also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different
cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.;
MeSH synonym : differentiation factor-2, b-cell; growth factor, hybridoma; il6; hybridoma growth factor; myeloid differentiation-inducing protein; plasmacytoma growth factor; growth factor, plasmacytoma; hepatocyte stimulating factor; b cell differentiation factor; b-cell differentiation factor-2; b cell differentiation factor 2; b-cell stimulatory factor 2; b-cell stimulatory factor-2; bsf-2; differentiation factor, b-cell; differentiation factor, b cell; differentiation factor 2, b cell; hepatocyte-stimulating factor; ifn-beta 2; il-6; mgi-2; differentiation-inducing protein, myeloid; myeloid differentiation inducing protein; b cell stimulatory factor-2; b cell stimulatory factor 2; b-cell differentiation factor; interleukin 6; Interferon beta-2; Interferon beta 2; beta-2, Interferon;
MeSH annotation : DF: IL 6 or IL6;
Wikipedia link : https://en.wikipedia.org/wiki/Interleukin 6;
Is substance : O;
Origin ID : D015850;
UMLS CUI : C0021760;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Indexing information
- TJU 103 [MeSH Supplementary Concept]
Record concept(s)
Related MeSH Supplementary Concept(s)
- SANT-7 [MeSH Supplementary Concept]
See also
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is
also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different
cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.
https://www.cochrane.org/fr/CD013881/EMERG_les-medicaments-qui-bloquent-linterleukine-6-une-proteine-impliquee-dans-la-reaction-excessive-du
2023
false
false
false
France
United Kingdom
COVID-19
review of literature
french abstract
proteins
interleukin-6
Interleukin-6
protein, nos
pharmaceutical preparations
drug, nos
immune response, nos
---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/Outil_clinique_Usage-Tocilizumab-Sarilumab.pdf
2021
false
false
true
Canada
French
Interleukin-6
quebec
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
drug therapy, combination
glucocorticoids
adult
aged
Interleukin 6 receptor antagonist (disposition)
guidelines for drug use
receptors, interleukin-6
biological therapy
pneumonia, viral
coronavirus infections
antibodies, monoclonal, humanized
pandemics
COVID-19
---
https://www.who.int/fr/news/item/06-07-2021-who-recommends-life-saving-interleukin-6-receptor-blockers-for-covid-19-and-urges-producers-to-join-efforts-to-rapidly-increase-access
2021
Switzerland
COVID-19
scientific and technical information
health planning guidelines
interleukin-6
disease
life
world health organization
physical exertion
exertion, nos
requested by patient
patients
Interleukin-6
---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/COVID-19_INESSS_biotherapie_IL-1.pdf
2020
false
false
true
Canada
pneumonia, viral
coronavirus infections
Interleukin-6
quebec
siltuximab
siltuximab
tocilizumab
tocilizumab
sarilumab
sarilumab
treatment outcome
guideline
receptors, interleukin-6
biological therapy
interleukin-6
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
antibodies, monoclonal, humanized
COVID-19
---
Levels of interleukin-6 in identifying severely ill adult patients with sepsis
https://www.cochrane.org/fr/CD011811/taux-dinterleukine-6-dans-lidentification-des-patients-adultes-gravement-malades-atteints-de-sepsie
2019
false
true
false
false
France
United Kingdom
Evidence-Based medicine
sepsis
review of literature
french abstract
critical illness
adult
sepsis
Interleukin-6
---